Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Researchers in the United States have successfully cured type 1 diabetes in mice using a “chimeric” immune system, allowing ...

NEW YORK--(BUSINESS WIRE)--Kallyope, Inc., a clinical stage biotechnology company discovering and developing novel, oral small-molecule therapeutics for diseases with high unmet need, today announced ...

The National Institutes of Health has provided $3.5 million for a large-scale clinical trial testing a radical new approach to managing type 2 diabetes that, in an earlier study, put almost 70% of ...

A new strategy may help prevent or slow the progression of Type 1 diabetes. A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the ...

The QBSAFE agenda-setting kit (ASK) is a novel patient-centric approach to diabetes care that has feasible study procedures and is well accepted by patients with type 2 diabetes and their clinicians.

Hello, and welcome to this market update with the Swedish Diabetes Research Company, Diamyd Medical. On Friday evening, the company announced negative interim results from its Phase III study. We will ...

INDIANAPOLIS — A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the progression of Type 1 diabetes by targeting an ...